Skip to main content

Table 3 Procedural characteristics

From: Clinical value of drug-coated balloon versus second-generation drug-eluting stent for de novo lesions in large coronary arteries: insights from the real world

 

Before propensity matching

 

After propensity matching

DCB

sDES

P-value

 

sDES

P-value

Number of patients

708

2149

  

704

 

Cutting or NSE balloon using, n (%)

650(91.9%)

N/A

  

N/A

 

Rotablator

22(3.1%)

185(8.6%)

<0.001

 

30(4.3%)

0.250

Intravascular imaging

124(17.5%)

447(20.8%)

0.058

 

139(19.7%)

0.282

Device (DCB or sDES) parameter

      

 Diameter (mm)

3.0(3.0-3.5)

3.5(3.0-3.5)

<0.001

 

3.5(3.0-3.5)

<0.001

 Length (mm)

24.85 ± 7.21

27.74 ± 7.85

<0.001

 

26.82 ± 8.01

<0.001

 inflated time (sec)

70(60,80)

10(10,10)

<0.001

 

10(10,10)

<0.001

 Device/RVD ratio

0.94(0.91–0.97)

0.95(0.92-1.0)

<0.001

 

0.97(0.92-1.0)

<0.001

DCB excessive inflated time, n (%)

463(65.4%)

N/A

  

N/A

 

Residual stenosis (%)

21.22 ± 5.43

11.99 ± 3.17

<0.001

 

12.27 ± 3.17

<0.001

Residual stenosis>30%, n (%)

10(1.4%)

0(0%)

<0.001

 

0(0%)

0.002

Dissection after procedure

      

 Type A, n (%)

121(17.1%)

20(0.9%)

<0.001

 

8(1.1%)

<0.001

 Type B, n (%)

54(7.6%)

4(0.2%)

<0.001

 

1(0.1%)

<0.001

 Type C, n (%)

8 (1.1%)

0

<0.001

 

0

0.008

  1. Notes: DCB, Drug-coated balloon; sDES, second-generation drug-eluting stent; NSE, Nitinol Spine Balloon; RVD, reference vessel diameter; continuous variables were presented as mean ± standard deviation or median (interquartile range, IQR); categoric variables were shown as number (%)